Mainstreaming Latent Tuberculosis Infection Testing and Treatment in the United States: Who and How

JAMA Intern Med. 2017 Dec 1;177(12):1764-1765. doi: 10.1001/jamainternmed.2017.4916.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cost-Benefit Analysis*
  • Humans
  • Latent Tuberculosis*
  • Mainstreaming, Education
  • Tuberculin Test
  • Tuberculosis
  • United States